Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells

被引:23
作者
Shibakura, M
Niiya, K
Niiya, M
Asaumi, N
Yoshida, C
Nakata, Y
Tanimoto, M
机构
[1] Okayama Univ, Fac Hlth Sci, Sch Med, Dept Med Technol, Okayama 7008558, Japan
[2] Okayama Univ, Fac Med, Sch Med, Dept Med 2, Okayama 7008558, Japan
关键词
acute promyelocytic leukemia; ATRA; chemokine; APL differentiation syndrome;
D O I
10.1016/j.leukres.2005.01.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously reported the induction of interleukin-8 (IL-8), one of the CXC chemokines, by all-traps retinoic acid (ATRA) in PL-21 and NB4 human myeloid leukemia cells, which may be implicated in APL differentiation syndrome that is a relatively frequent complication in patients with acute promyelocytic leukemia (APL) during treatment with ATRA. We, therefore, further investigated the effects of ATRA on the expression of chemokine family in NB4 cells and APL cells prepared from two APL patients. The RNase protection assay using a multi-probe template set for human chemokines revealed that ATRA induced gene expressions of a number of CC chemokines, such as monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta in NB4 cells. Their antigen levels were also increased in the cultured media. APL cells prepared from two APL patients showed gene expression of chemokines, such as IL-8, MCP-1, MIP-1 alpha, and MIP-1 beta when stimulated with ATRA in vitro. Furthermore, serum levels of IL-8, MIP-1 beta and RANTES were increased during the course of ATRA treatment in both APL patients who developed APL differentiation syndrome. These chemokines are all chemoattractants of particular inflammatory cell types, including neutrophils, monocytes and lymphocytes; therefore, the simultaneous induction of these chemokines after stimulation with ATRA may exacerbate the hyper-inflammation observed in ATRA-induced APL differentiation syndrome. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 16 条
  • [1] BURN TC, 1994, BLOOD, V84, P2776
  • [2] Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia
    De Botton, S
    Dombret, H
    Sanz, M
    San Miguel, J
    Caillot, D
    Zittoun, R
    Gardembas, M
    Stamatoulas, A
    Condé, E
    Guerci, A
    Gardin, C
    Geiser, K
    Makhoul, DC
    Reman, O
    de la Serna, J
    Lefrere, F
    Chomienne, C
    Chastang, C
    Degos, L
    Fenaux, P
    [J]. BLOOD, 1998, 92 (08) : 2712 - 2718
  • [3] DUBOIS C, 1994, BLOOD, V83, P3264
  • [4] THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA
    FRANKEL, SR
    EARDLEY, A
    LAUWERS, G
    WEISS, M
    WARRELL, RP
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) : 292 - 296
  • [5] Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
    Gerard, C
    Frossard, JL
    Bhatia, M
    Saluja, A
    Gerard, NP
    Lu, B
    Steer, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 2022 - 2027
  • [6] GIANNI M, 1995, EUR CYTOKINE NETW, V6, P157
  • [7] Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome
    Goodman, RB
    Strieter, RM
    Martin, DP
    Steinberg, KP
    Milberg, JA
    Maunder, RJ
    Kunkel, SL
    Walz, A
    Hudson, LD
    Martin, TR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) : 602 - 611
  • [8] Hsu HC, 1999, EUR J HAEMATOL, V63, P11
  • [9] Lalor Patricia F, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004155
  • [10] LANOTTE M, 1991, BLOOD, V77, P1080